About John Hoppin
John Hoppin is a chief executive officer and director at Ratio Therapeutics.
John Hoppin first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name John Hoppin in the role, so the role may have started earlier or lasted longer.
Ratio Therapeutics, Inc.
Chief Executive Officer and director
2023 – 2026 · Boston, MA
Develops targeted radioactive medicines for people with cancer.
Key Colleagues at Startups
The people John Hoppin works with at each company, as listed on that company's latest Form D.
Ratio Therapeutics, Inc. · Form D, Jul 31, 2026
SM
Scott MacDonald
Executive officer
MB
Marc Becker
Chief Financial Officer and Chief Operating Officer
AH
Albert Holman
Director
BI
Brandon Ingersoll
Director
AG
Allan Green
Director
WC
William Cowan
Director
JB
John Babich
Chief Scientific Officer and director
SW
Susan Whoriskey
Director